<code id='B86454FC98'></code><style id='B86454FC98'></style>
    • <acronym id='B86454FC98'></acronym>
      <center id='B86454FC98'><center id='B86454FC98'><tfoot id='B86454FC98'></tfoot></center><abbr id='B86454FC98'><dir id='B86454FC98'><tfoot id='B86454FC98'></tfoot><noframes id='B86454FC98'>

    • <optgroup id='B86454FC98'><strike id='B86454FC98'><sup id='B86454FC98'></sup></strike><code id='B86454FC98'></code></optgroup>
        1. <b id='B86454FC98'><label id='B86454FC98'><select id='B86454FC98'><dt id='B86454FC98'><span id='B86454FC98'></span></dt></select></label></b><u id='B86454FC98'></u>
          <i id='B86454FC98'><strike id='B86454FC98'><tt id='B86454FC98'><pre id='B86454FC98'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:19694
          Franklin faces
          Adobe

          Biotech and life sciences investors continue to draw in new funds even as the biotech stock indexes reach new lows.

          On Wednesday, VC firm Bioluminescence Ventures launched with $477 million to invest in biotech startups. The firm was founded by Kouki Harasaki, who was previously a partner at M12, Microsoft’s corporate venture group, and Andreessen Horowitz. He also has a track record at pharmaceutical companies like Novartis and Baxalta.

          advertisement

          Bioluminescence joined at least four other firms — OrbiMed, Sofinnova Partners, Abingworth, and Revelation Partners — in announcing new pools of capital in the last two weeks. Together, they have raised $5.94 billion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Anxious about a speech? A startup wants you to pop a minty cardiac drug
          Anxious about a speech? A startup wants you to pop a minty cardiac drug

          APSTockThepillworkslikemagic,peoplewho’veuseditsay,toquelltheiranxietyaroundpublicspeaking.Fordecade

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

          AdobeDiagnosticerrors—thatis,overlookingadisease,ordiagnosingiterroneouslyorlate—areaknownoccurrence